|
May 1, 2008
The Thunder Bay Regional Research Institute and Thunder Bay
Regional Health Sciences Centre (TBRHSC) unveiled their new
PET/CT imaging program today.
“This leading-edge technology will be a key component
of the Thunder Bay Regional Research Institute’s molecular
imaging and advanced diagnostics agenda. Our career and clinical
scientists will soon have access to the best PET technology
in the world. It’s a great start to our molecular imaging
research program,” says Mr. Keith Jobbitt, Chair of
the Board, Thunder Bay Regional Research Institute.
The new PET/CT unit, the 64-Slice Philips Gemini TF, is considered
the most advanced technology in PET imaging, using TruFlight
technology to achieve “time of-flight” imaging.
TruFlight delivers faster scans, better image quality and
the most advanced platform available for demanding molecular
imaging applications. The machine will be operated by the
research institute and housed at TBRHSC’s Regional Cancer
Centre, given the majority of patients who will benefit from
the research are cancer patients.
Working within the molecular imaging program of the research
institute, Career Scientist Dr. Alla Reznik and Founding Scientific
Director Dr. John Rowlands will conduct research on how to
improve current PET technology and ideally create the scanner
of the future. Cancer patients in Northwestern Ontario will
soon be offered PET/CT studies in accordance with approved
clinical trials and research studies in Ontario.
“PET research is a non-invasive analysis of the efficacy
of treatment, whether it’s radiation or chemotherapy.
It provides a quantitative analysis of the treatment efficacy,”
says Dr. Rowlands.
“Basically PET/CT research allows us to detect cancer
more precisely because we’re looking at it on a molecular
level. If we’re detecting disease more precisely, it
will reduce the impact of more invasive procedures like surgery
and assist in treatment planning,” says Mr. Michael
Power, Acting CEO, Thunder Bay Regional Research Institute.
The new research program will cost approximately $4.5 million
in upfront capital costs with the operating support provided
by provincial and national research grants. The capital funding
was provided by FedNor, Ontario Heritage Fund, Philips Healthcare
and Cancer Care Ontario.
What is PET/CT?
PET-CT stands for Positron Emission Tomography - Computerized
Tomography. The imaging device combines both imaging tools
(PET and CT) so that images acquired from both devices can
be taken at the same time, in the same session from the patient
and combined into a single image. Because they take different
kinds of images, when the images are combined it gives a more
detailed view of the activity in the body and therefore treatment
and diagnosis can be more precise.
:: back to Media Releases ::
|